Triazole inhibitors of Cryptosporidium parvum inosine 5′- monophosphate dehydrogenase

Journal of Medicinal Chemistry

Volumn 52, Issue 15, 2009, Pages 4623-4630

  Maurya, Sushil K ^a   Gollapalli, Deviprasad R ^a   Kirubakaran, Shivapriya ^a   Zhang, Minjia ^a   Johnson, Corey R ^a   Benjamin, Nicole N ^a   Hedstrom, Lizbeth ^a   Cuny, Gregory D ^b  

^a BRANDEIS UNIVERSITY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3 TRIAZINE DERIVATIVE; BOVINE SERUM ALBUMIN; INOSINATE DEHYDROGENASE; INOSINATE DEHYDROGENASE INHIBITOR;

ARTICLE; BIOLOGICAL WARFARE; BIOSYNTHESIS; CARBON NUCLEAR MAGNETIC RESONANCE; CATALYSIS; CHEMICAL STRUCTURE; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DRUG POTENCY; DRUG SELECTIVITY; DRUG SYNTHESIS; DRUG TARGETING; ENANTIOMER; ENZYME ACTIVITY; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; NONHUMAN; PARASITE; PROTON NUCLEAR MAGNETIC RESONANCE; PROTOZOAL INFECTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIPROTOZOAL AGENTS; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; ENZYME INHIBITORS; IMP DEHYDROGENASE; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZOLES;

EID: 68549104260     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm900410u     Document Type: Article

References (30)

1. Hedstrom, L. IMP dehydrogenase: mechanism of action and inhibition. Curr. Med. Chem. 1999, 6, 545-560.
2. Jackson, R. C.; Weber, G. IMP dehydrogenase, an enzyme linked with proliferation and malignancy. Nature 1975, 256, 331-333.
3. Zimmermann, A.; Gu, J. J.; Spychala, J.; Mitchell, B. S. Inosine monophosphate dehydrogenase expression: transcriptional regulation of the type I and type II genes. Adv. Enzyme Regul. 1996, 36, 75-84.
4. Shu, Q.; Nair, V. Inosine monophosphate dehydrogenase (IMPDH) as a target in drug discovery. Med. Chem. Rev. 2008, 28, 219-232.
5. Chen, L.; Pankiewicz, K. W. Recent development of IMP dehydrogenase inhibitors for the treatment of cancer. Curr. Opin. Drug Discovery Dev. 2007, 10, 403-412.
6. Nair, V.; Shu, Q. Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery. Antivir. Chem. Chemother. 2007, 18, 245-258.
7. Ratcliffe, A. J. Inosine 5′-monophosphate dehydrogenase inhibitors for the treatment of autoimmune diseases. Curr. Opin. Drug Discovery Dev. 2006, 9, 595-605.
8. Zhang, R. G. E.; Rotella, F.; Westbrook, E.; Huberman, E.; Joachimiak, A.; Collart, F. R. Differential signatures of bacterial and mammalian IMP dehydrogenase enzymes. Curr. Med. Chem. 1999, 6, 537-543.
9. Huang D. B.; White, A. C. An updated review on Cryptosporidium and Giardia. Gastroenterol. Clin. North Am. 2006, 35, 291-314, viii.
10. Abrahamsen, M. S.; Templeton, T. J.; Enomoto, S.; Abrahante, J. E.; Zhu, G.; Lancto, C. A.; Deng, M.; Liu, C.; Widmer, G.; Tzipori, S.; Buck, G. A.; Xu, P.; Bankier, A. T.; Dear, P. H.; Konfortov, B. A.; Spriggs, H. F.; Iyer, L.; Anantharaman, V.; Aravind, L.; Kapur, V. Complete genome sequence of the apicomplexan Cryptosporidium parvum. Science 2004, 304, 441-445.
11. Xu, P; Widmer, G.; Wang, Y.; Ozaki, L. S.; Alves, J. M.; Serrano, M.G.; Puiu, D.; Manque, P.; Akiyoshi, D.; Mackey, A. J.; Pearson, W. R.; Dear, P. H.; Bankier, A. T.; Peterson, D. L.; Abrahamsen, M. S.; Kapur, V.; Tzipori, S.; Buck, G. A. The genome of Cryptosporidium hominis. Nature 2004, 431, 1107-1112.
12. Umejiego, N. N.; Li, C.; Riera, T.; Hedstrom, L.; Striepen, B. Cryptosporidium parvum IMP dehydrogenase. J. Biol. Chem. 2004, 279, 40320-40327.
13. Striepen, B.; White, M. W.; Li, C.; Guerini, M. N.; Malik, S.-B.; Logsdon, J. M. Jr.; Liu, C.; Abrahamsen, M. S. Genetic complementation in apicomplexan parasites. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 6304-6309.
14. Gargala, G. Drug treatment and novel drug target against Cryptosporidium. Parasite 2008, 15, 275-281.
15. Umejiego, N. N.; Gollapalli, D.; Sharling, L.; Volftsun, A.; Lu, J.; Benjamin, N. N.; Stroupe, A. H.; Riera, T. V.; Striepen, B.; Hedstrom, L. Targeting a prokaryotic protein in a eukaryotic pathogen: identification of lead compounds against cryptosporidiosis. Chem. Biol. 2008, 15, 70-77.
16. Mancuso, A. J.; Swern, D. Activated dimethyl sulfoxide: useful reagent for synthesis. Synthesis 1981, 165-185.
17. Corey, E. J.; Fuchs, P. L. A synthetic method for formyl→ethynyl conversion (RCHO→RC≡CH or RC≡CR′). Tetrahedron Lett. 1972, 13, 3769-3772.
18. Hotha, S.; Kashyap, S. "Click chemistry" inspired synthesis of pseudo-oligosaccharides and amino acid glycoconjugates. J. Org. Chem. 2006, 71, 364-367.
19. Craig, W. A.; Ebert, S. C. Protein binding and its significance in antibacterial therapy. Infect. Dis. Clin. North Am. 1989, 3, 407-414.
20. Merrikin, D. J.; Briant, J.; Rolinson, G. N. Effect of protein binding on antibiotic activity in vivo. J. Antimicrob. Chemother. 1983, 11, 233-238.
21. Patani, G. A.; LaVoie, E. J. Bioisosterism: a rational approach in drug design. Chem. Rev. 1996, 96, 3147-3176.
22. Sharpless, K. B.; Manetsch, R. In situ click chemistry: a powerful means for lead discovery. Exp. Opin. Drug Discovery 2006, 1, 525-538.
23. Kolb, H. C.; Sharpless, K. B. The growing impact of click chemistry on drug discovery. Drug Discovery Today 2003, 8, 1128-1137.
24. Finn, M. G.; Sharpless, K. B. Click chemistry: diverse chemical function from a few good reactions. Angew. Chem., Int. Ed 2001, 40, 2004-2021.
25. Lee, T.; Cho, M.; Ko, S.-Y.; Youn, H.-J.; Baek, D. J.; Cho, W.-J.; Kang, C.-Y.; Kim, S. Synthesis and evaluation of 1,2,3-triazole containing analogues of the immunostimulant α-GalCer. J. Med. Chem. 2007, 50, 585-589.
26. Appendino, G.; Bacchiega, S.; Minassi, A.; Cascio, M. G.; De Petrocellis, L.; Di Marzo, V. The 1,2,3-triazole ring as a peptido- and olefinomimetic element: Discovery of click vanilloids and cannabinoids. Angew. Chem., Int. Ed. 2007, 46, 9312-9315.
27. Kim, S.; Cho, M.; Lee, T.; Lee, S.; Min, H. Y.; Lee, S. K. Design, synthesis, and preliminary biological evaluation of a novel triazole analogue of ceramide. Bioorg. Med. Chem. Lett. 2007, 17, 4584-4587.
28. Bock, V. D.; Speijer, D.; Hiemstra, H.; van Maarseveen, J. H. 1,2,3-Triazoles as peptide bond isosteres: synthesis and biological evaluation of cyclotetrapeptide mimics. Org. Biomol. Chem. 2007, 5, 971-975.
29. Brik, A.; Alexandratos, J.; Lin, Y. C.; Elder, J. H.; Olson, A. J.; Wlodawer, A.; Goodsell, D. S.; Wong, C. H. 1,2,3-Triazole as a peptide surrogate in the rapid synthesis of HIV-1 protease inhibitors. ChemBioChem 2005, 6, 1167-1169.
30. Horne, W. S.; Yadav, M. K.; Stout, C. D.; Ghadiri, M. R. Heterocyclic peptide backbone modifications in an alpha-helical coiled coil. J. Am. Chem. Soc. 2004, 126, 15366-15367.